As of 2023, the net operating surplus in Scientific R&D in the US was substantial. Forecasts indicate a slight year-on-year decline from 2024 to 2028, decreasing from 3.42 to 3.18 billion USD. The compound annual growth rate (CAGR) over this five-year period implies an average contraction due to consecutive reductions in surplus values.
Future trends to watch for include:
- The impact of government policies on research funding.
- Advancements in technology potentially altering the investment landscape.
- Economic fluctuations that could either hinder or boost R&D activities.
